Back to results
US 2008/0167380 A1Published application
Acyl Hydrazines as Kinase Inhibitors, in Particular for Sgk
AssigneeMerck Patent GmbH
InventorsRolf Gericke, Dieter Dorsch, Werner Mederski, Markus Klein, Norbert Beier, Florian Lang
Life of this patent
Estimating the term…
Abstract
Novel acyl hydrazides of the formula (I), in which R1-R9 have the meanings indicated in claim 1, are SGK inhibitors and can be used for the treatment of SGK-induced diseases and complaints, such as diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary hypertonia, cardiovascular diseases and renal diseases, generally in fibroses and inflammatory processes of any type.
Claims30
Compounds of the formula I
- in which
- R1R2, R3, R4, R5,
- R6, R7, R8, R9 each, independently of one another, denote H, A, OSO2A, Hal, NO2, OR10, N(R10)2, CN, —[C(R10)2]nCOOR10, O—[C(R10)2]oCOOR10, SO3H, —[C(R10)2]nAr, —CO—Ar, O—[C(R10)2]nAr, —[C(R10)2]nHet, —[C(R10)2]nC≡CH, O—[C(R10)2]nC≡CH, —[C(R10)2]nCON(R10)2, —[C(R10)2]nCONR10N(R10)2, O—[C(R10)2]nCON(R10)2, O—[C(R10)2]oCONR10N(R10)2, NR10COA, NR10CON(R10)2, NR10SO2A, N(SO2A)2, COR10, S(O)mAr, SO2NR10 or S(O)mA,
- R1 and R2, R2 and R3,
- R3 and R4 or R4 and R5 together also denote CH═CH—CH═CH,
- A denotes unbranched or branched alkyl having 1-6 C atoms, in which 1-7H atoms may be replaced by F, or cyclic alkyl having 3-7 C atoms,
- Ar denotes phenyl, naphthyl or biphenyl, each of which is unsubstituted or mono-, di- or trisubstituted by Hal, A, OR10, N(R10)2, NO2, CN, phenyl, CON(R10)2, NR10COA, NR10CON(R10)2, NR10SO2A, COR10, SO2N(R10)2, S(O)mA, —[C(R10)2]o—COOR10 and/or —O[C(R10)2]o—COOR10,
- Het denotes a mono- or bicyclic saturated, unsaturated or aromatic heterocycle having 1 to 4 N, O and/or S atoms, which may be mono-, di- or trisubstituted by Hal, A, OR10, N(R10)2, NO2, CN, COOR10, CON(R10)2, NR10COA, NR10SO2A, COR10, SO2NR10, S(O)mA, ═S, ═NR10 and/or ═O (carbonyl oxygen),
- R10 denotes H or A,
- Hal denotes F, Cl, Br or I,
- m denotes 0, 1 or 2,
- n denotes 0, 1, 2 or 3,
- 0 denotes 1, 2 or 3,
- and pharmaceutically usable derivatives, salts, solvates and stereoisomers thereof, including mixtures thereof in all ratios.
11 more elements
Dependencies are inferred from the claim text.